Heart Failure Diagnosis and Treatment
Heart failure is a syndrome, not a diagnosis. How to recognise it, classify it properly, and build treatment that follows the physiology rather than the label.
Cardiomyopathy has become a phenotype-first field. Dilated, hypertrophic, restrictive, arrhythmogenic and infiltrative disease increasingly separate on the basis of imaging signature, genotype and biomarker pattern rather than ejection fraction alone. Posts in this archive cover echocardiographic and cardiac MRI characterisation, when to escalate to nuclear imaging or endomyocardial biopsy, the practical reach of genetic testing and family screening, sudden death risk stratification, and the arrival of targeted therapy in amyloidosis and obstructive hypertrophic disease. Sports and pregnancy counselling appear where they change management. Readers wanting a systematic base can pair these with our heart failure, rhythm and risk course books and the diagnosis and imaging series.
Heart failure is a syndrome, not a diagnosis. How to recognise it, classify it properly, and build treatment that follows the physiology rather than the label.